Insights Into Gilead (GILD) Q1: Wall Street Projections for Key MetricsZacks Investment Research • 04/22/24
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024Business Wire • 04/08/24
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as SixBusiness Wire • 03/28/24
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 ProgramBusiness Wire • 03/28/24
Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of DirectorsBusiness Wire • 03/27/24
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy ManufacturingBusiness Wire • 03/26/24
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 03/19/24
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink GrantBusiness Wire • 03/18/24